Urinary tract infection
Therapeutic area
Infectious Disease
Rare disease
No
- Genetic basis
- No
- Non-human condition
- No
- Rare disease
- No
- Listing at source
- Listed
- Condition name
- Urinary tract infection
- Therapeutic area
- Infectious Disease
- urinary tract infection
- urinary tract infection (disease)
- Disease mechanisms
- Acquired
- Severity
- Mild
- Infectious Disease
- Nephrology
- MONDO ID
- MONDO:0100338
- Parent condition
- MONDO:0002118
Related records
Broader conditions (7)
- Disease
- Disease by body system or component
- Disease by etiologic mechanism
- Disease of primarily extrinsic mechanism
- Human disease
- Infectious disease
- Urinary system disorder
Narrower conditions (27)
- Acute cystitis
- Acute gonococcal cystitis
- Acute pyelonephritis
- Adenovirus renal infection
- Bacterial urinary tract infection
- BK-virus nephropathy
- Chronic pyelonephritis
- Gonococcal cystitis
- Gonococcal urethritis
- Hantavirus hemorrhagic fever with renal syndrome
- Hantavirus hemorrhagic fever with renal syndrome, Dobrava-Belgrade virus type
- Hantavirus hemorrhagic fever with renal syndrome, Puumala virus type
- Hantavirus hemorrhagic fever with renal syndrome, Seoul virus type
- Neonatal urinary tract infectious disease
- Pyelonephritis
- Pyoureter
- Renal infectious disease
- Renal tuberculosis
- Trichomonal vulvovaginitis
- Trichomonas cystitis
Trials (711)
- 'Improving Urinary Tract Infection Diagnosis in Older Patients: Validation of a Biomarker Panel (UTI-GOLD)'
- 7-day Compared With 10-day Antibiotic Treatment for Febrile Urinary Tract Infections in Children
- A Biochip for Rapid Diagnosis of Complicated Urinary Tract Infection
- A Bioequivalence Study of Cefadroxil Film Coated Tablets After A Single Oral Dose Administration to Healthy Subjects
- A Clinical Trial of Extended (High) Treatment Dose Antibiotics in Combination With Methenamine Hippurate Compared to the Standard of Care (Either Prophylactic (Low) Dose Antibiotic Treatment or Methenamine Hippurate) in Females With Chronic Urinary Tract Infection
- A Clinical Trial to Investigate the Safety and Efficacy of D-Mannose on Symptoms of Urinary Tract Infection in Women
- A Comparative, Controlled Study to Evaluate the Clinical Accuracy of the Velieve U.S. UTI Urine Analysis Test System
- A Comparison of the Effectiveness and Safety of Levofloxacin to That of Ciprofloxacin in Treating Complicated Urinary Tract Infection and Acute Pyelonephritis.
- A Novel Probiotic-antibiotic Combination to Prevent Recurrent Urinary Tract Infections
- A Phase 2 Study Evaluating Efficacy, Safety and Tolerability of Different Doses and Regimens of Allocetra-OTS for the Treatment of Organ Failure in Adult Sepsis Patients
- A Phase IV Study of Cipro XR in Uncomplicated UTI
- A Randomized Control Trial Comparing Single vs. Multiple Application of Lidocaine Analgesia Prior to Urethral Catheterization Procedures
- A Randomized Trial of Preoperative Prophylactic Antibiotics Prior to Kidney Stone Surgery (Percutaneous Nephrolithotomy [PCNL])
- A Retrospective, Blinded Validation of a Host-response Based Diagnostics
- A Safety and Efficacy Study of Doripenem in Participants With Nosocomial Pneumonia, Complicated Intra-Abdominal Infections and Urinary Tract Infections
- A Study in Adolescent and Adult Female Participants to Evaluate Clinical Symptom Improvement and the Safety of Gepotidacin During Treatment of Uncomplicated Urinary Tract Infections (Acute Cystitis)
- A Study in Pediatric Participants Aged ≥2 to <12 Years With a Suspected or Confirmed Bacterial Infection or Receiving Prophylaxis Antibiotics
- A Study of Efficacy and Safety of Intravenous Cefiderocol (S-649266) Versus Imipenem/Cilastatin in Complicated Urinary Tract Infections
- A Study of Enterorenal Syndrome Assessed by Gastrointestinal Ultrasound Combined with Renal Artery Resistance Index
- A Study of LBP-EC01 in the Treatment of Acute Uncomplicated UTI Caused by Drug Resistant E. Coli (ELIMINATE Trial)
Approved drugs (37)
- Acetohydroxamic acid
- Amdinocillin pivoxil
- Amikacin sulfate
- Amoxicillin
- Avibactam sodium
- Aztreonam
- Cefaclor
- Cefepime hydrochloride
- Cefiderocol sulfate tosylate
- Cefixime
- Ceftazidime
- Ceftolozane sulfate
- Ceftriaxone sodium
- Cefuroxime axetil
- Cilastatin sodium
- Ciprofloxacin
- Ciprofloxacin hydrochloride
- Clavulanate potassium
- Doripenem
- Doripenem monohydrate
Drugs in development (52)
- Amikacin Early phase 1
- Ancremonam Phase 2
- Ascorbic acid Phase 2
- Avibactam Phase 2
- Benapenem Phase 2
- Cefditoren pivoxil Phase 3
- Cefepime Phase 3
- Cefiderocol Phase 2
- Ceftaroline fosamil Phase 2
- Ceftolozane Phase 2
- Ceftriaxone Phase 3
- Cephalexin Phase 2
- Cholecalciferol Phase 2
- Cilastatin Phase 3
- Clavulanic acid Phase 3
- Cranberry liquid preparation Phase 2
- D-mannose Phase 2
- Dexamethasone Phase 3
- Edetic acid Phase 3
- Enmetazobactam Phase 3
Other linked drugs (13)
- Ammonium chloride
- Betadex
- Ceftezole
- Cinoxacin
- Enoxacin
- Methenamine
- Mezlocillin
- Nalidixic acid
- Pidotimod
- Sulfacytine
- Sulfalene
- Sulfamethizole
- Sulfisoxazole